On June 22, the day before the fifth batch of national procurement bids, a group of pharmaceutical companies caught up with the "last train" in the true sense.

In the "Announcement of Drug Approval Documents Pending Information Release on June 22, 2021" issued by the State Food and Drug Administration, metoprolol tartrate tablets, ceftriaxone sodium for injection, ceftazolin sodium for injection, and cefuroxime for injection Sodium caprylate, docetaxel injection, and lansoprazole for injection are the fifth batch of nationally procured varieties, and another batch of companies have passed the consistency evaluation, rewriting the competition pattern of tomorrow's varieties at the last minute.